Free tool
FAERS Monitor: Acetic Acid 0.25% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018161 or its brand name (Acetic Acid 0.25% In Plastic Container, Acetic Acid, Glacial). Reports on generic versions are filed under their own applications.
Reports
359
Serious
283
79% of reports
Hospitalization
130
Death reported
28
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea41
- diarrhoea33
- toxicity to various agents33
- cough27
- dyspnoea25
- pain24
- coronary artery disease22
- drug ineffective21
- off label use21
- arthralgia20
- nasopharyngitis20
- cardiac disorder19
- dysphonia19
- muscle spasms19
- wheezing19
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 8 |
| 2012 | 9 |
| 2013 | 7 |
| 2014 | 11 |
| 2015 | 11 |
| 2016 | 22 |
| 2017 | 13 |
| 2018 | 37 |
| 2019 | 31 |
| 2020 | 15 |
| 2021 | 24 |
| 2022 | 38 |
| 2023 | 41 |
| 2024 | 25 |
| 2025 | 17 |
| 2026 | 29 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,800 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| coronary artery diseaseSignal | 22 | 42.6 | 28.4 | 853 |
| dysphoniaSignal | 19 | 19.0 | 12.3 | 308 |
| wheezingSignal | 19 | 18.8 | 12.1 | 303 |
| cardiac disorderSignal | 19 | 11.9 | 7.7 | 180 |
| toxicity to various agentsSignal | 33 | 11.5 | 8.3 | 307 |
| nasopharyngitisSignal | 20 | 6.4 | 4.2 | 86 |
| muscle spasmsSignal | 19 | 6.1 | 3.9 | 76 |
| coughSignal | 27 | 5.6 | 3.9 | 100 |
| nauseaSignal | 41 | 3.0 | 2.3 | 56 |
| diarrhoeaSignal | 33 | 3.0 | 2.2 | 43 |
| arthralgiaSignal | 20 | 2.8 | 1.8 | 22 |
| dyspnoeaSignal | 25 | 2.6 | 1.8 | 23 |
| painSignal | 24 | 2.3 | 1.6 | 17 |
| off label use | 21 | 1.4 | 0.9 | 2 |
| drug ineffective | 21 | 0.9 | 0.6 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.